Magnesium Citrate

Magnesium citrate is elemental magnesium bound to citric acid. It’s one of the most common and best-value supplemental forms: reasonably high in elemental magnesium (~16% in the anhydrous salt), well absorbed, and effective for general repletion — with a mild-to-moderate laxative effect that’s welcome for occasional constipation but means loose stools at higher doses. Two things are genuinely “citrate” rather than generic-magnesium: its reliable absorption relative to oxide, and its established role as an osmotic bowel-cleansing agent. For the mineral’s full evidence base, see Magnesium.

Absorption & Tolerability

Citrate is among the better-absorbed magnesium forms. An independent randomised, double-blind, placebo-controlled parallel trial (n=46, 300 mg elemental Mg/day) found magnesium citrate produced the greatest serum magnesium of the forms tested after both acute (24 h) and 60-day chronic supplementation, and the greatest salivary magnesium after chronic use — with citrate and amino-acid chelate both out-absorbing oxide on 24-h urinary excretion at 60 days ^{1Reference 1Walker et al. · 2003RCTMg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study — [randomised controlled trial, independent]View study →}. The older comparative human study of US commercial preparations reached the same conclusion — soluble organic salts outperform oxide on fractional absorption ^{2Reference 2Firoz et al. · 2001Clinical trialBioavailability of US commercial magnesium preparations — [comparative human study]View study →} — and a small single-dose crossover RCT found higher urinary and serum magnesium after citrate than oxide, though it was industry-sponsored and short (n=20) ^{3Reference 3Kappeler et al. · 2017RCTHigher bioavailability of magnesium citrate versus oxide by urinary excretion and serum levels after single-dose administration — [randomised crossover, industry-sponsored, n=20]View study →}. A 2024 comparative RCT confirms citrate sits in the well-absorbed tier alongside newer microencapsulated and organic forms, with side-effect profiles that track the dose delivered ^{4Reference 4Werner et al. · 2024RCTComparative clinical study on magnesium absorption and side effects after oral intake of microencapsulated magnesium versus other magnesium sources — [randomised controlled trial]View study →}.

The practical caveat is the same one that constrains all magnesium: fractional absorption falls as the single dose rises, and unabsorbed magnesium draws water into the gut osmotically. That is why citrate is best split across the day and taken with food if loose stools are a problem — and why the same property makes it useful as a laxative.

What the Evidence Says

General repletion. Citrate is a frequent choice in magnesium trials, so much of the general magnesium evidence — modest benefits for blood pressure, blood sugar and migraine, clearest in deficient people — is representative of what citrate delivers (see Magnesium). There is little that is uniquely “citrate” about those outcomes beyond its reliable absorption; no head-to-head trial shows citrate produces better clinical endpoints than another well-absorbed form.

Bowel preparation (a genuinely form-specific use). Magnesium citrate is a standard osmotic bowel-cleansing agent, most often combined with sodium picosulphate (SPMC). A systematic review and meta-analysis pooled 13 RCTs and found SPMC slightly more effective than polyethylene glycol (PEG) on cleansing quality (pooled RR 1.06) and better tolerated than PEG, and equally effective to sodium phosphate ^{5Reference 5van Lieshout et al. · 2017Meta-analysisSodium picosulphate with magnesium citrate as bowel preparation for colonoscopy: systematic review and meta-analysis — [meta-analysis]View study →}. This is a high-dose, short-duration clinical use — distinct from the low, divided doses used for repletion — and it is the clearest evidence base that is specifically about the citrate form.

Kidney stones — read the label carefully. Citrate salts reduce recurrence of calcium-containing kidney stones by raising urinary citrate and pH, and a Cochrane review supports citrate supplementation for this indication ^{6Reference 6Phillips et al. · 2015Systematic reviewCitrate salts for preventing and treating calcium-containing kidney stones in adults — [Cochrane systematic review]View study →}. But the best stone trials used potassium-magnesium citrate ^{7Reference 7Ettinger et al. · 1997RCTPotassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis — [randomised controlled trial]View study →}, and the Cochrane analysis pools citrate salts broadly — the anti-stone effect is driven by the citrate anion (and potassium), not by magnesium citrate as such. This is a citrate benefit, not a reason to pick magnesium citrate specifically for repletion.

Gap: citrate’s advantages — good absorption, low cost, an established laxative/bowel-prep role — are well documented. What is not established is any advantage in general-health clinical outcomes over other well-absorbed forms (glycinate, malate, chloride); the only robust comparative superiority is over magnesium oxide, and it is an absorption difference, not an outcome difference. Form choice here is mostly about dose, cost, and gut tolerance, not dramatic bioavailability gaps.

Dosage

Typical supplemental doses are 120–300 mg of elemental magnesium per day, divided; the full studied range runs to ~400 mg. Because ~16% of the anhydrous salt is elemental magnesium, that is roughly 750–1,900 mg of magnesium citrate compound — always check whether a label states elemental or compound weight, as hydrated/tribasic citrate is lower in elemental Mg (~11%). Higher single doses act as a saline (osmotic) laxative; bowel-prep protocols use much larger amounts under supervision. These are doses studied in research, not a personal recommendation — see Magnesium for the RDA (310–420 mg/day) and the supplemental upper limit (350 mg/day, which counts supplemental magnesium, not dietary).

Safety

Well tolerated at moderate doses; diarrhea is the dose-limiting effect, and abdominal cramping or loose stools are the usual signals to reduce or split the dose. Serious hypermagnesemia is rare with normal kidney function but real in renal impairment, where magnesium is not cleared efficiently and can accumulate — avoid unsupervised use in significant kidney disease. General magnesium interactions apply: separate from bisphosphonates and certain antibiotics (tetracyclines, fluoroquinolones) by ≥2 hours, as magnesium chelates them and reduces absorption; long-term proton-pump inhibitors can lower magnesium status. Full interaction and population detail is on the Magnesium hub.

Scope of this safety review (for honesty, not a claim):

• Interactions assessed? Yes — bisphosphonates, tetracycline/fluoroquinolone antibiotics, and long-term PPIs, all covered in full on the hub.
• Pregnancy/lactation assessed? Partly — magnesium is generally considered safe in pregnancy at RDA/dietary levels and citrate carries no form-specific pregnancy signal, but the laxative effect at higher doses is the relevant caution; see the hub for the nutrient-level assessment.
• Upper Limit? Yes — 350 mg/day from supplements (nutrient-level, on the hub). This is the limit for supplemental magnesium and does not restrict dietary magnesium.

References